Discontinuation report ROVAMYCINE 250 CAPSULE 750000 UNIT
| Report ID | 168007 |
| Drug Identification Number | 01927825 |
| Brand name | ROVAMYCINE 250 CAPSULE 750000 UNIT |
| Common or Proper name | Spiramycin Capsule |
| Company Name | ODAN LABORATORIES LTD |
| Market Status | DORMANT |
| Active Ingredient(s) | SPIRAMYCIN |
| Strength(s) | 750000UNIT |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 50 |
| ATC code | J01FA |
| ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2022-08-25 |
| Remaining supply date | 2022-11-30 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2022-08-26 | French | Compare |
| v1 | 2022-08-26 | English | Compare |
Showing 1 to 2 of 2